ArticleMolecular therapy oncolytics2023

Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia.

Justin C Boucher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.